TMEM168 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.574000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.311200E-01
Normal-vs-Stage2
7.521200E-01
Normal-vs-Stage3
4.254400E-01
Normal-vs-Stage4
4.993000E-01
Stage1-vs-Stage2
8.231400E-01
Stage1-vs-Stage3
3.309800E-01
Stage1-vs-Stage4
2.519600E-01
Stage2-vs-Stage3
5.359800E-01
Stage2-vs-Stage4
1.100810E-01
Stage3-vs-Stage4
1.906780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
7.315200E-01
Normal-vs-AfricanAmerican
3.616600E-01
Normal-vs-Asian
7.704600E-01
Caucasian-vs-AfricanAmerican
5.186800E-01
Caucasian-vs-Asian
1.749250E-01
AfricanAmerican-vs-Asian
2.300600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
7.794200E-01
Normal-vs-Female
7.451400E-01
Male-vs-Female
9.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.836800E-01
Normal-vs-Age(41-60Yrs)
8.099000E-01
Normal-vs-Age(61-80Yrs)
7.276000E-01
Normal-vs-Age(81-100Yrs)
9.041800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.586200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.104800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
9.677200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.621400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.811400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.541200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.559200E-01
Normal-vs-Daily Drinker
2.556400E-01
Normal-vs-Weekly Drinker
3.683800E-01
Normal-vs-Occasional Drinker
7.533200E-01
Normal-vs-Social Drinker
8.871000E-01
Non Drinker-vs-Daily Drinker
2.189400E-01
Non Drinker-vs-Weekly Drinker
5.851000E-01
Non Drinker-vs-Occasional Drinker
7.482600E-01
Non Drinker-vs-Social Drinker
2.950400E-01
Daily Drinker-vs-Weekly Drinker
5.530800E-01
Daily Drinker-vs-Occasional Drinker
1.331160E-01
Daily Drinker-vs-Social Drinker
9.904400E-02
Weekly Drinker-vs-Occasional Drinker
3.884400E-01
Weekly Drinker-vs-Social Drinker
2.025800E-01
Occasional Drinker-vs-Social Drinker
4.708000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.317500E-02
Normal-vs-Grade 2
2.398000E-02
Normal-vs-Grade 3
1.258840E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.214000E-01
Grade 1-vs-Grade 3
6.489000E-01
Grade 1-vs-Grade 4
9.317500E-02
Grade 2-vs-Grade 3
4.624200E-01
Grade 2-vs-Grade 4
2.398000E-02
Grade 3-vs-Grade 4
1.258840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.207000E-01
Normal-vs-NonDiabetic
7.627000E-01
Diabetic-vs-NonDiabetic
3.451400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.331600E-01
Normal-vs-NoPancreatitis
7.097800E-01
Pancreatitis-vs-NoPancreatitis
8.915200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.868400E-01
Normal-vs-N1
6.535800E-01
N0-vs-N1
1.627020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.155000E-01
Normal-vs-TP53-NonMutant
9.027600E-01
TP53-Mutant-vs-TP53-NonMutant
2.519400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
